瘤特异性CXCR6阳性前体CD8+ T细胞在转移性黑色素瘤中调解瘤控制
Yang Song1, Ji Chen1, Yaqin Zhang1
1Department of Cardio-Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Cellular oncology (Dordrecht, Netherlands)
|April 7, 2025
概括
研究人员确定了一种表达CXCR6的精疲力竭T细胞 (Texp) 的特定子集,该子集有效地对抗肺转移. 在小鼠中,转移这些CXCR6阳性Texp细胞显著减少了瘤和增强了免疫治疗反应.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
- 细胞疗法细胞疗法
背景情况:
- 采用细胞疗法 (ACT) 对癌症回归有希望,但受到瘤微环境中的T细胞功能障碍的限制.
- 识别特定的T细胞子集对于提高ACT疗效至关重要.
- 在这种情况下,开发了一种人工肺转移模型来研究T细胞子集.
研究的目的:
- 建立一个肺转移模型来检查T淋巴细胞子集.
- 确定用于采用细胞疗法 (ACT) 的有效T细胞子集.
- 为了研究耗尽的T细胞 (Tex) 和它们的子集在转移中的作用.
主要方法:
- 使用B16细胞建立了一个转移性肺黑色素瘤小鼠模型.
- 分析了瘤特异性的CD8+ T细胞,使用流式细胞计测用于表面标记物和转录因子.
- 排序的T细胞子集用于体外杀死试验和体内采用转移疗法.
主要成果:
- 耗尽的CD8+ T细胞 (Tex) 显示异质性;表达CXCR6的前体细胞保留了记忆特征.
- 耗尽CXCR6+前体的T (Texp) 细胞补充了Tex细胞,并显示出直接的瘤细胞毒性.
- 采用CXCR6+Texp细胞的移植显著减少了肺转移,并对免疫检查点阻塞作出反应.
结论:
- 在转移性组织中确定了一组抗原特异性CXCR6+Texp细胞.
- 这些CXCR6+Texp细胞是T细胞效应者的重要来源,具有直接的抗瘤活性.
- 转移CXCR6+Texp细胞有效降低了肺转移,为增强免疫疗法提供了见解.
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
740
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
740
01:22T Cell Activation and Clonal Selection
550
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
550
01:27Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411